propionyl-L-carnitine
Selected indexed studies
- Propionyl-L-carnitine for intermittent claudication. (Cochrane Database Syst Rev, 2021) [PMID:34954832]
- Propionyl-L-carnitine. (Drugs Aging, 1998) [PMID:9534023]
- Effect of Acute and Chronic Oral l-Carnitine Supplementation on Exercise Performance Based on the Exercise Intensity: A Systematic Review. (Nutrients, 2021) [PMID:34959912]
_Worker-drafted node — pending editorial review._
Connections
propionyl-L-carnitine protects against
propionyl-L-carnitine helps
Sources
- Effect of Acute and Chronic Oral l-Carnitine Supplementation on Exercise Performance Based on the Exercise Intensity: A Systematic Review. (2021) pubmed
- Propionyl-L-carnitine for intermittent claudication. (2021) pubmed
- Propionyl-L-carnitine. (1998) pubmed
- Propionyl-l-carnitine mitigates ischemia-reperfusion injury in rat epigastric island flaps. (2024) pubmed
- Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism. (1991) pubmed
- Effectiveness of Propionyl-L-Carnitine Supplementation on Exercise Performance in Intermittent Claudication: A Systematic Review. (2021) pubmed
- Propionyl l-carnitine: intermittent claudication and peripheral arterial disease. (2009) pubmed
- Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. (2004) pubmed
- The Effects of L-Carnitine, Acetyl-L-Carnitine, and Propionyl-L-Carnitine on Body Mass in Type 2 Diabetes Mellitus Patients. (2021) pubmed
- Metabolic therapy for cardiovascular diseases with propionyl L-carnitine. (2026) pubmed